BIO insider filings
BIO-RAD LABORATORIES, INC. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-11-12. Screen BIO transaction legs live →
Insider transaction summary — last 90 days
2026-08-23 to 2026-11-21, from the filings listed below: 17 insider filings (Forms 3/4/5). Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 3 legs across 3 filings by 3 insiders — 3,221 shares, $1,247,039 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 78.
- Largest priced transaction: sale of 1,400 shares @ $385.63 ($539,876) by BARRY JAMES, filed 2026-11-12.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Insider | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|
| BARRY JAMES — EVP, President, LSG | 3 | — | 1 leg · 1,400 sh · $539,876 | 11 |
| DiVincenzo Jonathan P. — President & COO | 3 | — | 1 leg · 919 sh · $358,842 | 7 |
| ENLOE COURTNEY C — EVP, General Counsel & Sec | 2 | — | 1 leg · 902 sh · $348,321 | 7 |
| Allison Schwartz — Director | 2 | — | — | 11 |
| SCHWARTZ NORMAN D — Chairman & CEO, Director, 10% owner | 2 | — | — | 11 |
| EVRAN SEDAT — EVP, Global Supply Chain | 2 | — | — | 10 |
| ENGELHARDT EVA ANETTE — EVP, President, CDG | 1 | — | — | 7 |
| Lakkaraju Roop Kalyan — EVP, Chief Financial Officer | 1 | — | — | 7 |
| Mehta Rajat — EVP, GBL Commercial Operations | 1 | — | — | 7 |
Recent insider filings — BIO-RAD LABORATORIES, INC.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-12 | 4 | DiVincenzo Jonathan P. — President & COO | Sale (S): 919 @ $390.47 | EDGAR |
| 2026-11-12 | 4 | ENLOE COURTNEY C — EVP, General Counsel & Sec | Sale (S): 902 @ $386.17 | EDGAR |
| 2026-11-12 | 4 | BARRY JAMES — EVP, President, LSG | Sale (S): 1,400 @ $385.63 | EDGAR |
| 2026-10-27 | 4 | DiVincenzo Jonathan P. — President & COO | Option exercise (M): 1,869 @ $0 · Tax withholding (F): 951 @ $369.95 · Option exercise (M): 1,869 (derivative) @ $0 | EDGAR |
| 2026-10-22 | 4 | EVRAN SEDAT — EVP, Global Supply Chain | Option exercise (M): 1,044 @ $0 · Tax withholding (F): 487 @ $354.50 · Option exercise (M): 1,044 (derivative) @ $0 | EDGAR |
| 2026-09-09 | 4 | BARRY JAMES — EVP, President, LSG | Option exercise (M): 1,027 @ $0 · Tax withholding (F): 369 @ $386.11 · Option exercise (M): 1,056 @ $0 · Tax withholding (F): 470 @ $386.11 · Grant/award (A): 4,313 (derivative) @ $0 · Option exercise (M): 1,027 (derivative) @ $0 · +1 more | EDGAR |
| 2026-09-09 | 4 | Allison Schwartz — Director | Option exercise (M): 228 @ $0 · Tax withholding (F): 82 @ $386.11 · Option exercise (M): 92 @ $0 · Tax withholding (F): 34 @ $386.11 · Grant/award (A): 719 (derivative) @ $0 · Option exercise (M): 228 (derivative) @ $0 · +1 more | EDGAR |
| 2026-09-09 | 4 | Lakkaraju Roop Kalyan — EVP, Chief Financial Officer | Option exercise (M): 1,370 @ $0 · Tax withholding (F): 559 @ $386.11 · Option exercise (M): 1,536 @ $0 · Tax withholding (F): 782 @ $386.11 · Grant/award (A): 6,326 (derivative) @ $0 · Option exercise (M): 1,370 (derivative) @ $0 · +1 more | EDGAR |
| 2026-09-09 | 4 | Mehta Rajat — EVP, GBL Commercial Operations | Option exercise (M): 456 @ $0 · Tax withholding (F): 233 @ $386.11 · Option exercise (M): 1,370 @ $0 · Tax withholding (F): 504 @ $386.11 · Grant/award (A): 4,601 (derivative) @ $0 · Option exercise (M): 456 (derivative) @ $0 · +1 more | EDGAR |
| 2026-09-09 | 4 | ENLOE COURTNEY C — EVP, General Counsel & Sec | Option exercise (M): 685 @ $0 · Tax withholding (F): 246 @ $386.11 · Option exercise (M): 768 @ $0 · Tax withholding (F): 305 @ $386.11 · Grant/award (A): 2,876 (derivative) @ $0 · Option exercise (M): 685 (derivative) @ $0 · +1 more | EDGAR |
| 2026-09-09 | 4 | DiVincenzo Jonathan P. — President & COO | Option exercise (M): 1,712 @ $0 · Tax withholding (F): 668 @ $386.11 · Grant/award (A): 6,326 (derivative) @ $0 · Option exercise (M): 1,712 (derivative) @ $0 | EDGAR |
| 2026-09-09 | 4 | ENGELHARDT EVA ANETTE — EVP, President, CDG | Option exercise (M): 1,027 @ $0 · Tax withholding (F): 369 @ $386.11 · Option exercise (M): 1,152 @ $0 · Tax withholding (F): 485 @ $386.11 · Grant/award (A): 4,313 (derivative) @ $0 · Option exercise (M): 1,027 (derivative) @ $0 · +1 more | EDGAR |
| 2026-09-09 | 4 | EVRAN SEDAT — EVP, Global Supply Chain | Option exercise (M): 1,027 @ $0 · Tax withholding (F): 329 @ $386.11 · Option exercise (M): 864 @ $0 · Tax withholding (F): 277 @ $386.11 · Grant/award (A): 4,026 (derivative) @ $0 · Option exercise (M): 1,027 (derivative) @ $0 · +1 more | EDGAR |
| 2026-09-09 | 4 | SCHWARTZ NORMAN D — Chairman & CEO, Director, 10% owner | Option exercise (M): 4,109 @ $0 · Tax withholding (F): 2,876 @ $386.11 · Option exercise (M): 3,455 @ $0 · Tax withholding (F): 1,854 @ $386.11 · Grant/award (A): 17,251 (derivative) @ $0 · Option exercise (M): 4,109 (derivative) @ $0 · +1 more | EDGAR |
| 2026-09-03 | 4 | SCHWARTZ NORMAN D — Chairman & CEO, Director, 10% owner | Option exercise (M): 5,087 @ $0 · Tax withholding (F): 2,336 @ $380.96 · Option exercise (M): 2,082 (derivative) @ $0 · Option exercise (M): 3,005 (derivative) @ $0 | EDGAR |
| 2026-09-03 | 4 | Allison Schwartz — Director | Option exercise (M): 117 @ $0 · Tax withholding (F): 43 @ $380.96 · Option exercise (M): 42 (derivative) @ $0 · Option exercise (M): 75 (derivative) @ $0 | EDGAR |
| 2026-09-03 | 4 | BARRY JAMES — EVP, President, LSG | Option exercise (M): 425 @ $0 · Tax withholding (F): 154 @ $380.96 · Option exercise (M): 174 (derivative) @ $0 · Option exercise (M): 251 (derivative) @ $0 | EDGAR |
| 2026-07-28 | 4 | ENGELHARDT EVA ANETTE — EVP, President, CDG | Option exercise (M): 246 @ $0 · Tax withholding (F): 89 @ $314.46 · Option exercise (M): 246 (derivative) @ $0 | EDGAR |
| 2026-05-13 | 4 | ENGELHARDT EVA ANETTE — EVP, President, CDG | Sale (S): 550 @ $246.54 | EDGAR |
| 2026-04-28 | 4 | ENLOE COURTNEY C — EVP, General Counsel & Sec | Option exercise (M): 186 @ $0 · Tax withholding (F): 77 @ $287.84 · Option exercise (M): 186 (derivative) @ $0 | EDGAR |
| 2026-04-28 | 4 | Lakkaraju Roop Kalyan — EVP, Chief Financial Officer | Option exercise (M): 1,078 @ $0 · Tax withholding (F): 420 @ $287.84 · Option exercise (M): 1,078 (derivative) @ $0 | EDGAR |
| 2026-04-23 | 4 | PEI MELINDA LITHERLAND — Director | Option exercise (M): 407 @ $0 · Grant/award (A): 369 (derivative) @ $0 · Option exercise (M): 407 (derivative) @ $0 | EDGAR |
| 2026-04-23 | 4 | PINKSTON ARNOLD A — Director | Option exercise (M): 407 @ $0 · Grant/award (A): 369 (derivative) @ $0 · Option exercise (M): 407 (derivative) @ $0 | EDGAR |
| 2026-04-23 | 4 | Hinckley Greg K — Director | Option exercise (M): 407 @ $0 · Grant/award (A): 369 (derivative) @ $0 · Option exercise (M): 407 (derivative) @ $0 | EDGAR |
| 2026-04-23 | 4 | EDWARDS JEFFREY L — Director | Option exercise (M): 407 @ $0 · Grant/award (A): 369 (derivative) @ $0 · Option exercise (M): 407 (derivative) @ $0 | EDGAR |
| 2025-11-10 | 4 | BARRY JAMES — EVP, President, LSG | Sale (S): 699.87 @ $306.18 | EDGAR |
| 2025-10-28 | 4 | DiVincenzo Jonathan P. — President & COO | Option exercise (M): 1,869 @ $0 · Tax withholding (F): 950 @ $339.75 · Option exercise (M): 1,869 (derivative) @ $0 | EDGAR |
| 2025-10-21 | 4 | EVRAN SEDAT — EVP, Global Supply Chain | Option exercise (M): 1,044 @ $0 · Tax withholding (F): 335 @ $321.90 · Option exercise (M): 1,044 (derivative) @ $0 | EDGAR |
| 2025-09-09 | 4 | Mehta Rajat — EVP, GBL Commercial Operations | Grant/award (A): 1,827 (derivative) @ $0 · Grant/award (A): 5,480 (derivative) @ $0 | EDGAR |
| 2025-09-09 | 4 | ENGELHARDT EVA ANETTE — EVP, President, CDG | Option exercise (M): 1,152 @ $0 · Tax withholding (F): 413 @ $295.43 · Grant/award (A): 4,110 (derivative) @ $0 · Option exercise (M): 1,152 (derivative) @ $0 | EDGAR |
| 2025-09-09 | 4 | BARRY JAMES — EVP, President, LSG | Option exercise (M): 1,056 @ $0 · Tax withholding (F): 378 @ $295.43 · Grant/award (A): 4,110 (derivative) @ $0 · Option exercise (M): 1,056 (derivative) @ $0 | EDGAR |
| 2025-09-09 | 4 | ENLOE COURTNEY C — EVP, General Counsel & Sec | Option exercise (M): 768 @ $0 · Tax withholding (F): 275 @ $295.43 · Grant/award (A): 2,740 (derivative) @ $0 · Option exercise (M): 768 (derivative) @ $0 | EDGAR |
| 2025-09-09 | 4 | EVRAN SEDAT — EVP, Global Supply Chain | Option exercise (M): 864 @ $0 · Tax withholding (F): 277 @ $295.43 · Grant/award (A): 4,110 (derivative) @ $0 · Option exercise (M): 864 (derivative) @ $0 | EDGAR |
| 2025-09-09 | 4 | COREY COLLEEN — EVP, Global Human Resources | Option exercise (M): 576 @ $0 · Tax withholding (F): 209 @ $295.43 · Grant/award (A): 2,740 (derivative) @ $0 · Option exercise (M): 576 (derivative) @ $0 | EDGAR |
| 2025-09-09 | 4 | Allison Schwartz — Director | Option exercise (M): 92 @ $0 · Tax withholding (F): 33 @ $295.43 · Grant/award (A): 914 (derivative) @ $0 · Option exercise (M): 92 (derivative) @ $0 | EDGAR |
| 2025-09-09 | 4 | DiVincenzo Jonathan P. — President & COO | Grant/award (A): 6,850 (derivative) @ $0 | EDGAR |
| 2025-09-09 | 4 | Lakkaraju Roop Kalyan — EVP, Chief Financial Officer | Option exercise (M): 1,535 @ $0 · Tax withholding (F): 550 @ $295.43 · Grant/award (A): 5,480 (derivative) @ $0 · Option exercise (M): 1,535 (derivative) @ $0 | EDGAR |
| 2025-09-09 | 4 | SCHWARTZ NORMAN D — Chairman & CEO, Director, 10% owner | Option exercise (M): 3,455 @ $0 · Tax withholding (F): 1,528 @ $295.43 · Grant/award (A): 16,439 (derivative) @ $0 · Option exercise (M): 3,455 (derivative) @ $0 | EDGAR |
| 2025-09-03 | 4 | BARRY JAMES — EVP, President, LSG | Option exercise (M): 602 @ $0 · Tax withholding (F): 217 @ $297.88 · Option exercise (M): 178 (derivative) @ $0 · Option exercise (M): 174 (derivative) @ $0 · Option exercise (M): 250 (derivative) @ $0 | EDGAR |
| 2025-09-03 | 4 | COREY COLLEEN — EVP, Global Human Resources | Option exercise (M): 1,102 @ $0 · Tax withholding (F): 398 @ $297.88 · Option exercise (M): 254 (derivative) @ $0 · Option exercise (M): 347 (derivative) @ $0 · Option exercise (M): 501 (derivative) @ $0 | EDGAR |
| 2025-09-03 | 4 | Allison Schwartz — Director | Option exercise (M): 147 @ $0 · Tax withholding (F): 55 @ $297.88 · Option exercise (M): 31 (derivative) @ $0 · Option exercise (M): 42 (derivative) @ $0 · Option exercise (M): 74 (derivative) @ $0 | EDGAR |
| 2025-09-03 | 4 | SCHWARTZ NORMAN D — Chairman & CEO, Director, 10% owner | Option exercise (M): 6,353 @ $0 · Tax withholding (F): 3,084 @ $297.88 · Option exercise (M): 1,266 (derivative) @ $0 · Option exercise (M): 2,082 (derivative) @ $0 · Option exercise (M): 3,005 (derivative) @ $0 | EDGAR |
| 2025-07-29 | 4 | ENGELHARDT EVA ANETTE — EVP, President, CDG | Option exercise (M): 245 @ $0 · Tax withholding (F): 88 @ $264.19 · Option exercise (M): 245 (derivative) @ $0 | EDGAR |
| 2025-04-25 | 4 | Lakkaraju Roop Kalyan — EVP, Chief Financial Officer | Option exercise (M): 1,077 @ $0 · Tax withholding (F): 386 @ $249.74 · Option exercise (M): 1,077 (derivative) @ $0 | EDGAR |
| 2025-04-25 | 4 | ENLOE COURTNEY C — EVP, General Counsel & Sec | Option exercise (M): 186 @ $0 · Tax withholding (F): 67 @ $249.74 · Option exercise (M): 186 (derivative) @ $0 | EDGAR |
| 2025-04-24 | 4 | PINKSTON ARNOLD A — Director | Option exercise (M): 308 @ $0 · Grant/award (A): 407 (derivative) @ $0 · Option exercise (M): 308 (derivative) @ $0 | EDGAR |
| 2025-04-24 | 4 | PEI MELINDA LITHERLAND — Director | Option exercise (M): 308 @ $0 · Grant/award (A): 407 (derivative) @ $0 · Option exercise (M): 308 (derivative) @ $0 | EDGAR |
| 2025-04-24 | 4 | HINCKLEY GREGORY K — Director | Option exercise (M): 308 @ $0 · Grant/award (A): 407 (derivative) @ $0 · Option exercise (M): 308 (derivative) @ $0 | EDGAR |
| 2025-04-24 | 4 | EDWARDS JEFFREY L — Director | Option exercise (M): 308 @ $0 · Grant/award (A): 407 (derivative) @ $0 · Option exercise (M): 308 (derivative) @ $0 | EDGAR |
| 2025-03-18 | 4 | Crowley Michael — EVP, GBL Commercial Operations | Option exercise (M): 3,000 @ $159.32 · Sale (S): 3,000 @ $247.06 · Option exercise (M): 3,000 (derivative) @ $0 | EDGAR |
Recent 8-K events — BIO-RAD LABORATORIES, INC.
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-11-04 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-04 | 8-K | 2.02 — Results of Operations and Financial Condition ? 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-30 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-24 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-19 | 8-K | 7.01 — Regulation FD Disclosure | EDGAR |
| 2026-02-12 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-10-29 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-09-30 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-08-26 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-07-31 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=BIO returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs